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ABSTRACT
To assess the magnitude of patient counseling in Palestine. a cross-sectional, questionnairebased, composed of four sections: demographics, information that participants wanted to be counseled about their medications, about their diseases, and reasons why counseling was not done. Results were analyzed using SPSS program.500 participants filled the questionnaire, majority (41.2%)
were in the age group of 20-29 years old, about half were females, and had medium income. More
than half lived in villages, were mainly healthy, and had a bachelor degree. Most participants
wanted to know how to use their medications (93.6%), therapeutic uses (92.6%), whether to be taken before or after meal (91.6%), and routes of administration (91.4%). Regarding their diseases,
participants wanted to know if is contagious (84.2%), possible exacerbations (83.2%), and duration
(82.6%). The reasons for not doing counseling were the desire to get the information from the physician (60%), or didn’t want to listen (55.6), lack of time (31%), or did not trust the pharmacists
(22.4%). Significant differences were found in gender and education in the desire for information.
Pharmacists-patient counseling is highly required. Modification of the curriculum is highly encouraged to adapt with the up-to-date needs to practice pharmacy
Keywords: counseling, pharmacist, patient, Palestine
INTRODUCTION
The practice of pharmacy has evolved
over the years to include not only preparation
and dispensing of medications, but also to
counsel patients through the provision of
pharmaceutical care. In community pharmacies, counseling is a relation between the
pharmacist and the patient in which the
pharmacist is dispensing medications, ensuring patient safety, providing information to
the patients about their medication use, side
effects, doses, storage, and drug interactions
[1-6].
Currently, drug information is available
from many sources including the internet,
books, advertisements, and health-care personnel. However, such information may be
confusing, inaccurate, or not clear for layman
[7]. To avoid any lack or misunderstanding,
pharmacist-patient counseling is the solution.
It has been proven that such counseling can
improve therapy outcome, reduce morbidity

and mortality, help in medication management, as well as reducing the occurrence of
adverse side effects [8-10]. Pharmacists are
the drug information providers thus they are
able to identify any possible drug-drug or
drug-food interactions, and to instruct patients on the correct use of their
medications[11, 12]. The role of pharmacist
in counseling and providing health information have had a significant impact on patients’ satisfaction, quality of care, improving
medication knowledge and adherence, can
reduce health care costs, and lowers rehospitalization rates after discharge, particularly when counseling is patient-guided [7,
13-16].
Counseling in the developed world,
pharmacist-patient counseling is required by
law in USA since the last decade, and research have shown that strict implementation
of this law is for the benefit of the patient
[17].To further encourage the advancement
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in patient counseling, the American Pharmacists Association and the Academy of Student
Pharmacists (APhA-ASP) has launched an
annual competition called the National Patient Counseling Competition to improve patient education [18].More than ten years ago,
the UK governments changed the vision for
pharmacy to include patient education [19].
The UK government is now paying close attention to community pharmacists and their
responsibilities in managing medication for
patients.
Few studies were conducted in the Arab
world pertaining to counseling, two were in
Qatar regarding public's attitudes towards
community pharmacy [20, 21]. Several issues
were raised in those studies, such as the insufficient time of contact between the patient
and the pharmacist, and the poor understanding of the public to the role of the pharmacist
in providing drug information, or in monitoring drug therapy, and that more efforts are
needed to promote the pharmacist role. In
Saudi Arabia, most customers were comfortable seeking advice and drug information
from the pharmacist [22]. In Jordan, people
thought highly of the community pharmacists
and about two thirds of the customers are
willing to seek information from them [23].
Public knowledge and medication-related
awareness and understanding is highly variable across the world. Nevertheless, patients
should recognize the importance of the medications for their health and wellbeing. Pharmacist-patient counseling may give the
needed information to patients to fill that gap
in knowledge, and to increase the benefits
and decrease the inappropriate and harmful
effects of medications. Pharmacists are the
last health-care providers whom the patient
sees before taking the medications, providing
the patients with the needed information from
the pharmacist may influence patients’ decision making, and decreases medication-errors
that results from limited knowledge.
To our knowledge, there were several studies conducted among community pharmacists in Palestine, considering aspects other
than pharmacists-patient counseling [24-32].
No studies have been done in Palestine regarding pharmacists-patient counseling and
what information do the patients want. In or-

der to provide this information for decision
makers and interested agencies, and to advise
national pharmacy schools to include courses
about communications and patients counseling in its curriculum, this study was conducted. This study will shed light on the patients’ perceptive on the importance of counseling, the type of drug or disease-related
information sought, and to assess participants’
opinion on the importance of pharmacists as
health care providers. Additionally, we aim
to identify the reasons and obstacles preventing effective pharmacist-patient counseling.
MATERIALS AND METHODS
Study design
This is a cross-sectional questionnairebased study designed to gather specific data
regarding pharmacist-patient counseling, it
was conducted in the period of September to
December- 2016. The population of the study
were randomly selected customers visiting
community pharmacies in the Northern areas
of Palestine; which includes 5 governorates:
Nablus, Qalqiliah, Jenin, Tubas, and Tulkarem. IRB approval was obtained, and each
participant gave verbal consent before filling
the questionnaire.
Sample size
Convenience sampling method was used
to randomly select participants from the
community pharmacies. The sample size was
calculated using Raosoft sample size calculator (http://www.raosoft.com/samplesize.html)
by allowing 5% margin of error at 95% confidence interval. The minimum effective
sample size was 374 participants. In order to
minimize erroneous results and increase the
study reliability, the target sample size was
increased to 500 participants.
The tool of the study
A semi-structured self-administered questionnaire was developed for the purpose of
this study. It was pilot-tested and modified.
The questionnaire consisted of both closedended and open-ended questions. The questionnaire is composed of four categories: (1)
The Socio-demographic section, (2) The drugrelated information that the participants
wanted to know, (3) Disease-related information that participants were interested in
knowing, and (4) The reasons why the infor-
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mation needed (or counseling) were not obtained.
The drug-related information section included questions about the side-effects of the
medications, medication storage, cost considerations, therapeutic uses, how to use the
medication, possible drug-drug and drugfood interactions, routes of administrations,
duration of use, and whether written or verbal
drug information is preferred. Disease-related
information section included the time frame
of the disease, possible exacerbations,
whether the disease is contagious, and the
port of transmission. The section pertaining
to why the information sought (or counseling) were not given, the options included: the
participants did not have enough time to listen, the participants did not want to listen for
whatever reason(s), the participants have
doubts regarding the pharmacists’ knowledge, and were not sure pharmacists could
be trusted, and finally, the participants
thought it’s better to obtain the information
they need from the treating physicians.

cial Science (SPSS) version 20. Frequencies
and percentages were calculated for categorical variables, while mean ± standard deviation (SD) were computed for continuous data. A p value of less than 0.05 was considered
statistically significant.
RESULTS AND DISCUSSION
Socio-demographic characteristics
A total sample of 500 customers were included in the study; mean age was 31.3 ±
15.5 years, females were a bit more than half
(55.6% of participants). Regarding income,
most participants (48.4%) had an average
income (based on local standards; between
2000-5000 New Israeli Sheikel (NIS))
(equivalent to 553-1383$) and 38%of them
were below average while 13.6% were above
average income. The majority of the participants (58.2%) were from villages, and
39.8%were from cities. The majority (69.4%)
had a Bachelor degree. Most participants
claimed to be healthy (82.6%), while the rest
( 17.4%) had one or more chronic disease
(Table 1).

STATISTICAL ANALYSIS
All data was entered into the computer
and analyzed via Statistical Package for SoTable(1): Socio-demographic characteristics of participants
Parameter
Gender
Income (NIS)*

Place of living

Educational level

Male
Female
Less than 2000
2000-5000
More than 5000
City
Village
Refugee camp
High school
BA
Higher education

Frequency
222
278
190
242
68
199
291
10
132
347
21

Percentage %
44.4
55.6
38
48.4
13.6
39.8
58.2
2
26.4
69.4
4.2

*NIS: New Israeli Shekel. Drug-related information sought by the study population.

Almost all participants (456; 91.2%) expressed that they would like to receive drugrelated information from the pharmacist.
The information they wanted to have pertained to the therapeutic uses of their medications (93.6%), whether the medication
should be taken before or after meals
(91.6%), the routes of administrations
(91.4%), the duration of use (90%), the potential side effects(89.2%), any possible

drug-drug interactions or drug–food interactions (83.8% and 87.2%, respectively), cost
considerations (66%), storage conditions
(78.4%),and wanted to have written drug
information as well (72.6%) (Table 2). A
study conducted in Ethiopia and in other
places have revealed that patients also requested similar information to what we
found in our study [7, 33-35]. This indicates
that patients are interested in knowing more
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about their medications, and that pharmacist-patient counseling will be very welcomed. In our study we found that (89.2%)
of participants were in need of information
about the side effects, while a study conducted in Malaysia found that only (8.1%)
of participants chose side effects as the most
common question they wanted answer to
[36]. This may be due to some type of concern that participants in our study had toward medications, which directs them toward seeking knowledge about the side effects.
The majority of participants (92.6%)
wanted to get more information about the
therapeutic use of their medications. This is
an agreement with a previous study in Saudi
Arabia, where pharmacists reported that
they provide information about drug dose in
71.1% of cases, medication use in 63.1%,
60.8% about use with food or empty stomach, 46.8% about duration of treatment, in
addition to purpose of medication, storage
condition, drug-drug and drug-food interaction [37]. There is a difference between the
study in Saudi Arabia since it was based on
what pharmacists provide, while ours is
mostly what patients wanted to know. Yet it
is a good study to support that patients want
and will listen to information about their
medications.
Table(2): Type of drug-related information
sought by participants
Drug-related information participants sought
Side effects
Therapeutic uses
Routes of administrations
How to use the medication
Duration of use
Whether to be taken before or after meals
Storage conditions
Cost considerations
Drug-drug interaction
Drug-food interaction
Whether they like to receive written drug information

Yes
(%)
89.2
92.6
91.4

No
(%)
10.8
7.4
8.6

93.6

6.2

90

10

91.6

8.4

78.4
66
83.8
87.2

21.6
34
16.2
12.8

72.6

27.4

Disease-related information sought by participants

Regarding disease-related information,
most (88%) of the participants would like to
receive information about the disease they
may have, in particular, the normal duration
of the disease (82.6%), possible exacerbations (83.2%), whether the disease is contagious (84.2%), and the route of transmission
(76%) (Table 3).
Table(3): Disease-related information participants would like to know
Disease-related information participants
would like to know
Disease duration
Possible exacerbations of
the disease
Whether the disease is
contagious
Port of transmission

Yes(%) No(%)
82.6

17.4

83.2

16.8

84.2

15.8

76

24

Reasons for not obtaining the sought
information from the pharmacist, or for
not performing counseling
While about one third (31%) of the participants did not have enough time to listen,
more than half of the study population (155;
55.6%) did not want to listen for reasons
they did not declare. About one fourth (112;
22.4%) of the participants had doubts regarding the pharmacists’ knowledge and
were not sure they could trust what the
pharmacist tells them. Finally, more than
half (300; 60%) of participants thought it’s
better to obtain the information they need
from the treating physicians (Table 4). Furthermore, a study conducted in Malaysia
about pharmacist-patient counseling showed
that one third of the respondents felt that the
lack of time was the major barrier faced
while counseling patients, followed by lack
of patients’ interest, and lack of knowledge
by the pharmacist [36].
A study conducted in Egypt reported similar barriers that prevented the pharmacists
from conducting professional and adequate
counseling [38]. In Denmark, it was found
that the keys to good patient-pharmacist
counseling were the knowledge of the pharmacist and the dialogue between the pharmacist and the customers [39]. Estonian customers wanted counseling by the pharmacist
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that ensures favored privacy, discretion and
confidentiality [40].

about their disease being contagious or not (p
value= 0.041).

Other studies have also found gaps and
deficiencies exist in the counseling provided
by pharmacists in content and delivery method [41]. A study from Saudi Arabia found
that the main reason for not providing counseling was that the pharmacist was too busy
[37].The practice of counseling in India is
currently insignificant and lagging behind
[42]. However, the pharmacist-patient counseling in many countries in general, and Palestine in particular, should develop to meet
the changing needs of the modern society.

Female participants were more interested
in getting more drug-related information than
male participant with a high percent (92.4%)
of them (p value= 0.00). and the dose (p value= 0.047). There were gender-related differences in responses to other questions, but
none were significant.

Table(4): Reasons for not obtaining the information from pharmacists
Reasons for not obtaining the
sought information

Yes %

The participants did not have
enough time to listen.

31.0 69.0

No %

The participants did not want to
listen for whatever reason(s)
55.6 44.4
they had.
The participants have doubts
regarding the pharmacists’
22.4 77.6
knowledge, and were not sure
they could be trusted.
The participants thought it’s better to obtain the information they
60.0 40.0
need about drugs or diseases
from the treating physicians
Analysis of the results suggest that the
level of income did not have a significant
effect on participants’ desire to obtain information, indicating that all participants would
like to have more information about their
medications or diseases regardless of their
income.
Among the participants, village residents
had more interests in getting drug-related
information compared to city or camp residents (p value= 0.005). Additionally, they
were significantly more interested in getting
written drug information (p value= 0.018).
villagers also were more interested in getting
disease-related information (51.2% of participants), however the difference was not significant. In particular, they sought information

As for education, it was found that participants with bachelor degrees had more interest in getting drug-related information specially the dose (p value= 0.027), drug-drug
interaction (p value= 0.027), and mood of
disease transmission (p value= 0.009).
There is continuous need to improve the
currently performed counseling worldwide
since it represents the professional mission of
the pharmacists [43]. It is important to keep
in mind that in order to have a successful patient counseling session, it should to be personalized, since studies have shown that such
settings result in better outcomes and better
customer satisfaction[44].
In order to provide up-to-date information
for patients, pharmacists need continuing education programs, especially for pharmacists who
are working in close or daily contact with patients. It is also of great importance to add communication skill courses to pharmacy curriculum
at the Palestinian schools of pharmacy, such
courses are not less important than academic
courses.
Increased patients’ awareness nowadays has
created the need for special consultation areas in
the pharmacy to enable the patient and the
pharmacist to feel comfortable discussing personal medical issues. Application of this type of
medical privacy is available in some developed
countries and we recommend to apply it everywhere to maintain patients’ privacy and comfort
while receiving medical care.
Our study has limitations, for example
we did not take the pharmacists’ opinions of
counseling into account, another limitation is
that the information was collected via a selfadministered questionnaire, thus the responses may have contained some inaccurate
data resulting from poor or misunderstanding
of the questions. Recall bias and having li-
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mited time to answer the questionnaire may
be another limitation. We recommend the
implementation of pharmacist-patient counseling, and to address patients’ questions and
give them the needed information about their
medications and diseases, in order to improve
the therapeutic outcome. Additionally,
awareness and knowledge should be established among pharmacists about the importance of counseling and to have it as courses
that can be given during college years, or
through continuing educations.
CONCLUSIONS
The results of the current study indicated
that pharmacist counseling is highly needed
and desired by the patients. This was obvious
from their responses, since they indicated
that it was important for them to get essential
instructions and information about their medications and diseases. Patient counseling is
very important but was not effectively fulfilled by most Palestinian pharmacists. This
is due to many reasons that has to do with the
patients and the pharmacists.
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